Aligos Therapeutics, Inc. (ALGS) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$24.19M | +81.6% |
| 2024 | -$131.21M | -49.6% |
| 2023 | -$87.68M | +8.7% |
| 2022 | -$96.05M | +25.2% |
| 2021 | -$128.33M | -18.2% |
| 2020 | -$108.54M | -107.7% |
| 2019 | -$52.26M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$24.19M | +81.6% |
| 2024 | -$131.21M | -49.6% |
| 2023 | -$87.68M | +8.7% |
| 2022 | -$96.05M | +25.2% |
| 2021 | -$128.33M | -18.2% |
| 2020 | -$108.54M | -107.7% |
| 2019 | -$52.26M | — |